Close Menu

Hwang Woo-Suk is continuing his comeback. According to Nature News, Hwang has applied for a new license to work with human embryonic stem cells. The Korean science ministry is scheduled to decide on that license by this coming April. Hwang is still on trial for fraud, embezzlement, and for breaches of bioethics laws.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.